Skip to main content
C

Careset

This platform analyzes Medicare claims data to map patient journeys and provide real-world evidence for targeted drug therapies. By decoding patient experiences, the platform helps ensure patients receive appropriate and timely treatments.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Pharmaceutical and biotech companies often struggle to gain a comprehensive understanding of patient journeys and treatment patterns due to incomplete Medicare claims data, including blocked or redacted information. This lack of visibility hinders effective physician targeting, market access strategies, and informed decision-making throughout the drug lifecycle.

Solution

CareSet provides a Medicare data analytics platform that decodes complex Medicare A, B, and D claims data, including previously blocked brands, accounts, and payor data points, to uncover comprehensive patient journeys and provider influence. By mapping patient experiences from diagnosis to treatment, CareSet enables pharmaceutical companies to identify key spending trends, understand physician behavior, and optimize market access strategies. The platform offers census-level insights, revealing physicians’ diagnostic criteria, treatment patterns, and complex prescribing behaviors, empowering pharma teams to navigate market access, adoption, and brand performance with real-world evidence.

Target Audience

The primary target audience includes pharmaceutical and biotech companies, particularly those involved in market access, commercial operations, regulatory affairs, and clinical trial recruitment, seeking to leverage Medicare data for strategic decision-making.

Features

  • Analysis of 100% of Medicare A, B, C, and D claims data, including previously blocked or redacted data.
  • Monthly census-level insights into patient flows and prescribing patterns.
  • NPI-labeled provider network data, revealing physicians' diagnostic criteria and treatment patterns.
  • Patient journey mapping, tracking disease progression and treatment pathways.
  • MarketView insights for market sizing and forecasting by indication, treatment, and brand.
  • Identification of key opinion leaders (KOLs) and their networks for clinical trial recruitment.
  • Monthly alerts on physician-level activity for informed field decision-making.
  • IRA Part D Spending Dashboard to identify high-cost drugs and manage rebates.
This profile is AI-generated and may contain inaccuracies.